Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48.6Revenue (TTM) $M4.8Net Margin (%)-26.8Altman Z-Score1.6
Enterprise Value $M45.2EPS (TTM) $--Operating Margin %-23.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.0Pre-tax Margin (%)-26.8Higher ROA y-yN
Price/Book9.910-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsY
Price/Sales10.65-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-178.6ROA % (ttm)-14.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-26.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M65.4ROIC % (ttm)-26.1Gross Margin Increase y-yY

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IGXT is held by these investors:



IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-11-30Sell25,000$0.750view
Durham John EdwardVP Manufacturing 2016-10-07Buy3,000$0.76-1.32view
Durham John EdwardVP Manufacturing 2016-09-21Buy10,000$0.83-9.64view
Godin AndreEVP & CFO 2016-09-14Buy20,000$0.724.17view
Boudreau BernardDirector 2016-01-22Buy65,000$0.4953.06view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.550view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.487.5view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.5244.23view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.5147.06view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.550view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com

More From Other Websites
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Mar 28 2017
IntelGenx Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 28 2017
Oral Film Exclusivity Granted to IntelGenx' VersaFilm(TM) for Tadalafil Erectile Dysfunction Dosing... Mar 28 2017
IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 -... Mar 21 2017
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Mar 13 2017
IntelGenx Engages Kilmer Lucas for Cross-Border Investor Relations Mar 13 2017
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Feb 09 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and... Feb 09 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017
/DISREGARD RELEASE: IntelGenx Technologies Corp./ Jan 30 2017
/DISREGARD RELEASE: IntelGenx Technologies Corp./ Jan 30 2017
IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2 Jan 30 2017
IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2 Jan 30 2017
IntelGenx Grants Stock Options Jan 19 2017
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)